Search

Search Results
Results 17501 - 17510 of 18774 for breast cancer
  • Drug - 19 Jun 2025
    Consumer Medicine Information (CMI) about Avapro HCT intended for persons living in Australia.
  • Drug - 10 Jun 2025
    Consumer Medicine Information (CMI) about Imbruvica intended for persons living in Australia.
  • News - 1 Jun 2025
    A global resolution on digital marketing of breast milk substitutes must be rigorously enforced, writes Afshan Khan, Assistant Secretary-General of the United Nations and coordinator of the Scaling Up...
  • Drug - 26 May 2025
    Consumer Medicine Information (CMI) about Fingolimod-Teva intended for persons living in Australia.
  • News - 21 May 2025
    High birth weight is the main risk factor for birth injuries to the anal sphincter muscles of the person giving birth, according to a study at the University of Gothenburg.
  • Drug - 15 Apr 2025
    Consumer Medicine Information (CMI) about Kaletra intended for persons living in Australia.
  • News - 9 Apr 2025
    Today, Mirvie announced results of a breakthrough study published in Nature Communications, revealing new advances in the biological understanding of hypertensive disorders of pregnancy (HDP),...
  • Drug - 3 Apr 2025
    Consumer Medicine Information (CMI) about Prolia intended for persons living in Australia.
  • Drug - 31 Mar 2025
    Consumer Medicine Information (CMI) about Increlex (mecasermin) intended for persons living in Australia.
  • News - 11 Mar 2025
    It would be greatly beneficial to physicians trying to save lives in intensive care units if they could be alerted when a patient's condition rapidly deteriorates or shows vitals in highly abnormal...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.